RNAConnect® Announces Commercial Launch of UltraMarathonRT® cDNA Synthesis and Amplification Kit for Enhanced Short-Read RNA Sequencing

BRANFORD, Conn., Aug. 27, 2025 /PRNewswire/ — RNAConnect, a leader in next-generation molecular biology tools, today announced the commercial launch of the UltraMarathonRT cDNA Synthesis and Amplification Kit, designed to elevate short-read RNA sequencing workflows. This kit unleashes the power of UltraMarathonRT (uMRT) to deliver unprecedented sensitivity and breadth of transcript detection and quantification, even for the most challenging transcripts.

“UltraMarathonRT represents a significant leap forward for RNA-seq,” said Dr. Jason Underwood, Vice President, Technology Development at RNAConnect. “By harnessing uMRT, researchers can now uncover RNA species and transcriptional complexity that were previously masked – especially rare isoforms and long noncoding RNAs – unlocking new avenues for biomarker discovery and basic research.”